Drug Development Archives - Oncology Central Oncology Central

i
i

21 Jan 2020 Immuno-oncology
Newfound killer T cell could target most cancers
21 Jan 2020 Preclinical research and trials
Old drugs, new tricks: several non-oncology drugs can kill cancer cells
15 Jan 2020 Breast
Palbociclib receives NICE approval as combination therapy for advanced breast cancer
17 Dec 2019 Clinical trials
Future Oncology: best of 2019
27 Aug 2019 Journal Articles
The rise of oncology biosimilars: from process to promise
15 Aug 2019 Brain and neurologic
Drug-inducible gene therapy for glioblastoma shows promise in clinical trial
8 Aug 2019 Lung
Pembrolizumab receives the green light from NICE for NSCLC subtype
2 Aug 2019 Journal Articles
Sequential afatinib and osimertinib in patients with EGFR mutation-positive NSCLC: updated analysis of the observational GioTag study
24 Jul 2019 News
PARP inhibitors: study uncovers novel mechanism of action
17 Jul 2019 Journal Articles
MONALEESA clinical program: a review of ribociclib use in different clinical settings
15 Jul 2019 Videos
Improving clinical trial success with Carla Balch
12 Jul 2019 Breast
Palbociclib and crizotinib combination could overcome tumor treatment resistance